Viemed Healthcare (VMD) Set to Post Quarterly Earnings on Wednesday

Key Points

• Viemed Healthcare is expected to report Q3 2026 results after market close on November 4. Analysts forecast earnings of $0.12 per share and revenue of $80.78 million; the earnings call is scheduled for November 5 at 11:00 a.m. ET.
• The company’s previous quarter fell short on earnings, reporting $0.07 per share versus the $0.12 consensus estimate, while revenue of $78.1 million slightly exceeded expectations.
• Viemed shares recently traded at $9.68, and analysts maintain a consensus “Hold” rating with a $14.00 price target, despite one firm initiating coverage with an “Outperform” rating.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) is projected to announce its Q3 2026 results after the market closes on Wednesday, November 4th. Analysts expect Viemed Healthcare to announce earnings of $0.12 per share and revenue of $80.78 million for the quarter. Individuals can check the company's upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Thursday, November 5, 2026 at 11:00 AM ET.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last released its earnings results on Monday, August 3rd. The company reported $0.07 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.05). The company had revenue of $78.10 million during the quarter, compared to analysts' expectations of $78.00 million. On average, analysts expect Viemed Healthcare to post $0.41 EPS for the current fiscal year and $0.54 EPS for the next fiscal year.

Viemed Healthcare Trading Down 0.5%

NASDAQ VMD opened at $9.68 on Wednesday. The business's 50-day moving average price is $9.17 and its 200 day moving average price is $9.50. Viemed Healthcare has a twelve month low of $6.05 and a twelve month high of $12.61. The company has a market capitalization of $368.69 million, a PE ratio of 26.89 and a beta of 1.04.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the stock. Barrington Research assumed coverage on shares of Viemed Healthcare in a research note on Monday, August 24th. They set an "outperform" rating and a $14.00 price objective for the company. Weiss Ratings lowered shares of Viemed Healthcare from a "buy (b-)" rating to a "hold (c+)" rating in a report on Monday, August 17th. Freedom Capital cut shares of Viemed Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, August 5th. Finally, Wall Street Zen downgraded shares of Viemed Healthcare from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 15th. One investment analyst has rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $14.00.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc NASDAQ: VMD is a U.S. healthcare company that provides in-home medical equipment and clinical services for patients with chronic respiratory and other complex medical conditions. Its services are designed to help patients receive care at home while supporting hospitals and clinicians in managing ongoing conditions.

The company's offerings include non-invasive ventilation, oxygen therapy, sleep-apnea equipment, respiratory therapy, remote patient monitoring and related durable medical equipment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.